- CFO Spotlights
- Profiles
- Joseph M. Busky
Profile
Joseph M. Busky
Chief Financial Officer (Principal Financial and Accounting Officer), QuidelOrtho Corporation
Former. First published here October 28, 2026; built from records as of October 28, 2026.
QuidelOrtho Corporation named Micah Young to succeed Joseph M. Busky, effective July 6, 2026.2
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| QuidelOrtho Corporation (QDEL) In Vitro & In Vivo Diagnostic Substances | Chief Financial Officer (Principal Financial and Accounting Officer) | Former |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- July 6, 2026effective
QuidelOrtho Corporation named Micah Young to succeed Joseph M. Busky, effective July 6, 2026. Profile of Micah Young.
[2] Filing by QuidelOrtho Corporation, filed with the SEC on June 23, 2026. Read the filing. The record at CFO Tribune.
- February 19, 202610-K filed
Joseph M. Busky signed the annual report of QuidelOrtho Corp on Form 10-K as Chief Financial Officer (Principal Financial and Accounting Officer), filed February 19, 2026.
/s/ J OSEPH M. B USKY Chief Financial Officer (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by QuidelOrtho Corp, filed with the SEC on February 19, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, QuidelOrtho Corp. U.S. Securities and Exchange Commission, EDGAR, filed February 19, 2026. sec.gov; record.
- Current report filed with the SEC, QuidelOrtho Corporation. U.S. Securities and Exchange Commission, EDGAR, filed June 23, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Joseph M. Busky wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.